Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
80 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07775313 | Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM | enrolling by invitation | Phase 1 / Phase 2 | 10 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Sep 30, 2026 | clinicaltrials |
| NCT00967785 | A Phase I Study of Mozobil in the Treatment of Patients With WHIMS | completed | Phase 1 / Phase 2 | 14 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Sep 28, 2026 |
| clinicaltrials |
| NCT01905826 | Natural History Study of GATA2 Deficiency and Related Disorders | recruiting | — | 600 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Sep 22, 2026 | clinicaltrials |
| NCT00044122 | Study of Factors Regulating Mast Cell Proliferation | recruiting | — | 700 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Sep 16, 2026 | clinicaltrials |
| NCT06908096 | Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection | recruiting | Phase 1 | 750 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Sep 8, 2026 | clinicaltrials |
| NCT00867269 | Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia | recruiting | — | 950 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07778459 | Expanding HOPE Liver | recruiting | — | 80 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Aug 21, 2026 | clinicaltrials |
| NCT04645147 | Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults | completed | Phase 1 | 83 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Aug 13, 2026 | clinicaltrials |
| NCT00032513 | Genetic Studies of Chronic Active Epstein-Barr Disease | recruiting | — | 300 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Jul 28, 2026 | clinicaltrials |
| NCT05026138 | Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) | recruiting | — | 850 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Jul 6, 2026 | clinicaltrials |
| NCT02231879 | Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome | completed | Phase 2 / Phase 3 | 20 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Jun 26, 2026 | clinicaltrials |
| NCT05683834 | Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons | completed | Phase 1 / Phase 2 | 25 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Apr 22, 2026 | clinicaltrials |
| NCT00044304 | Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome | active not recruiting | Phase 2 | 70 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Mar 16, 2026 | clinicaltrials |
| NCT04761822 | COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations(SARS) | completed | Phase 2 | 746 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Aug 12, 2025 | clinicaltrials |
| NCT03770273 | Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis | completed | Phase 2 | 21 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Dec 17, 2024 | clinicaltrials |
| NCT03921515 | Skin Immunity Sample Collection Involving Blisters and Biopsies | withdrawn | Early Phase 1 | 0 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Dec 13, 2024 | clinicaltrials |
| NCT00001756 | Study of Mast Cell Precursors | completed | — | 202 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 7, 2022 | clinicaltrials |
| NCT02496676 | Magnesium Supplementation in People With XMEN Syndrome | completed | Phase 1 / Phase 2 | 8 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Mar 2, 2022 | clinicaltrials |
| NCT00000712 | A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3 | completed | Phase 2 | 400 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 4, 2021 | clinicaltrials |
| NCT00000758 | A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women | completed | Phase 3 | 158 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 2 | Nov 4, 2021 | clinicaltrials |
| NCT00000987 | A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS | completed | Phase 1 | 36 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 4, 2021 | clinicaltrials |
| NCT00000994 | A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 3 | 240 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 4, 2021 | clinicaltrials |
| NCT00000996 | A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | 48 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 4, 2021 | clinicaltrials |
| NCT00001004 | A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex | completed | Phase 2 | 30 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 4, 2021 | clinicaltrials |
| NCT00001073 | Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors | completed | Phase 3 | 150 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 3 | Nov 4, 2021 | clinicaltrials |
| NCT00001113 | A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma | completed | Phase 1 | 48 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 4, 2021 | clinicaltrials |
| NCT00000658 | A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma | completed | Phase 3 | 250 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 3, 2021 | clinicaltrials |
| NCT00000660 | Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma | completed | Phase 1 | 24 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 3, 2021 | clinicaltrials |
| NCT00000681 | A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma | completed | Phase 1 | 24 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 3, 2021 | clinicaltrials |
| NCT00000687 | Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma | completed | Phase 2 | 60 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 3, 2021 | clinicaltrials |
| NCT00000703 | Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | completed | N/A | 45 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 3, 2021 | clinicaltrials |
| NCT00000725 | A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma | completed | Phase 1 | 56 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 3, 2021 | clinicaltrials |
| NCT00000763 | A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma | completed | Phase 1 | 42 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 3, 2021 | clinicaltrials |
| NCT00000646 | Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS | completed | Phase 1 | 54 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 2, 2021 | clinicaltrials |
| NCT00000689 | Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma | completed | Phase 1 | 18 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 2, 2021 | clinicaltrials |
| NCT00000694 | A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma | completed | Phase 1 | 18 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 2, 2021 | clinicaltrials |
| NCT00000695 | Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma | completed | Phase 1 | 36 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 2, 2021 | clinicaltrials |
| NCT00001114 | The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma | completed | Phase 2 | 90 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 2 | Nov 1, 2021 | clinicaltrials |
| NCT00001116 | A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients | completed | N/A | 18 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 1, 2021 | clinicaltrials |
| NCT00013871 | Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs | completed | N/A | 300 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 2 | Nov 1, 2021 | clinicaltrials |
| NCT00000954 | A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma | completed | Phase 1 | 72 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Oct 29, 2021 | clinicaltrials |
| NCT00000723 | The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer | terminated | N/A | 45 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Oct 28, 2021 | clinicaltrials |
| NCT00000764 | Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. | completed | Phase 1 | 98 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Oct 28, 2021 | clinicaltrials |
| NCT00000769 | A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma | completed | Phase 1 | 48 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Oct 28, 2021 | clinicaltrials |
| NCT00000807 | Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy | completed | Phase 2 | 41 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Oct 28, 2021 | clinicaltrials |
| NCT00000626 | Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease | completed | Phase 2 | 27 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Oct 27, 2021 | clinicaltrials |
| NCT00837434 | Anti-TNF Agents for the Treatment of Rheumatoid Arthritis | completed | Phase 4 | 63 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Sep 22, 2021 | clinicaltrials |
| NCT00050193 | Cause and Natural Course of Pediatric-Onset Mastocytosis | completed | — | 103 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01672918 | Fluorodeoxyglucose Imaging Studies to Detect Lymphoma | withdrawn | — | 0 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 0 | Dec 5, 2019 | clinicaltrials |
| NCT00557895 | Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders | terminated | — | 288 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 25, 2019 | clinicaltrials |
Data updated 12 hours agoSource updated unknownsource: clinicaltrials